Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer (Q60368025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Kenneth J. Pienta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

M G Sanda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L G Charles

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Hwang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Schlom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Milenic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Panicali

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J E Montie

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

260-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Abnormalities of cell-mediated immunocompetence in genitourinary cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900539-1

7 January 2021

10.1016/S0090-4295(98)00539-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933036%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference